These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 10025760

  • 1. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ.
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
    Grundmann-Kollmann M, Korting HC, Behrens S, Kaskel P, Leiter U, Krähn G, Kerscher M, Peter RU.
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
    Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, Boehncke WH, Kerscher M, Kaufmann R, Peter RU.
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M, David M, Mimouni D.
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil.
    Zwerner J, Fiorentino D.
    Dermatol Ther; 2007 Oct; 20(4):229-38. PubMed ID: 17970888
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolic acid in dermatology a century after its discovery.
    Strathie Page SJ, Tait CP.
    Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM, Albert S, Al Fares S, Harman KE, Setterfield J, Bhogal B, Black MM.
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [Abstract] [Full Text] [Related]

  • 8. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE.
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.
    Kawashita MY, Tsai K, Aoki V, Santi CG, Maruta CW, Rivitti E.
    J Dermatol; 2005 Jul; 32(7):574-80. PubMed ID: 16335874
    [Abstract] [Full Text] [Related]

  • 10. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy.
    Grundmann-Kollmann M, Kaskel P, Leiter U, Krähn G, Behrens S, Peter RU, Kerscher M.
    Arch Dermatol; 1999 Jun; 135(6):724-5. PubMed ID: 10376713
    [No Abstract] [Full Text] [Related]

  • 11. Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone.
    Scheinfeld N.
    J Dermatolog Treat; 2007 Jun; 18(4):243-5. PubMed ID: 17671884
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M, David M, Mimouni D.
    Immunol Allergy Clin North Am; 2012 May; 32(2):309-15, vii. PubMed ID: 22560143
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S, Platamone A, Alaimo R, Bongiorno MR.
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate in dermatology.
    Liu V, Mackool BT.
    J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil in dermatology.
    Orvis AK, Wesson SK, Breza TS, Church AA, Mitchell CL, Watkins SW.
    J Am Acad Dermatol; 2009 Feb; 60(2):183-99; quiz 200-2. PubMed ID: 19150270
    [Abstract] [Full Text] [Related]

  • 16. Coexistent psoriasis and bullous pemphigoid responding to mycophenolate mofetil monotherapy.
    Rallis E, Anyfantakis V.
    Skinmed; 2008 Feb; 7(2):101-2. PubMed ID: 18327004
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H, Ishii N, Hamada T, Karashima T, Nakama T, Yasumoto S, Hashimoto T.
    Eur J Dermatol; 2010 Feb; 20(4):472-5. PubMed ID: 20406724
    [Abstract] [Full Text] [Related]

  • 18. Characteristics and Management of Autoimmune Bullous Disease in Psoriasis Patients.
    Toh JJ, Lim YL, Yew YW.
    Ann Acad Med Singap; 2019 Sep; 48(9):301-305. PubMed ID: 31737896
    [No Abstract] [Full Text] [Related]

  • 19. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
    Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
    [Abstract] [Full Text] [Related]

  • 20. Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
    Nigam R, Levitt J.
    J Drugs Dermatol; 2012 May; 11(5):622-5. PubMed ID: 22527431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.